This study has provided theoretical reference for further study on the anti-tumor mechanism of VP-16.
从而为医学工作者进一步了解和探讨VP-16的抗肿瘤机理提供了直接的理论依据。
2
Methods 56 patients with SCLC were randomly divided into treatment group and control group receiving ce (Carboplatin, Etoposide VP-16) regimen plus Lifein or ce regimen alone respectively.